
    
      The study cohort will include 150 patients with fatty liver per ultrasound or histology. The
      patients will be divided randomly to one of three arms: follow up group, lifestyle
      modification group, and statins therapy (Atorvastatin 20mg/d for 6 months). at screening,
      after 6 months (end of treatment), and 12 months the patients will undergo:

        1. complete physical examination

        2. blood pressure measurement

        3. assessment of height and weight, body mass index and waist circumference

        4. blood samples for complete blood count, fasting plasma glucose, fasting plasma insulin,
           lipid profile, liver enzymes, albumin, bilirubin, Prothrombin time (PT INR), Hemoglobin
           A1c, ferritin, adiponectin, C-reactive protein, Tumor necrosis factor alpha,
           Lipoprotein-phospholipase A2, Apolipoproteins B100, A1, C3, C4, ceruloplasmin

        5. Liver elastography and sonographic liver fat quantification

        6. Brachial artery flow-mediated dilatation (FMD) measurement
    
  